M. Tellier

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review

V. Gaborieau, A. Sommet, R. Favory, 2021, Fundamental & clinical pharmacology.

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

C. A. Shaw, Eglantine Ferrand Devouge, Su Hwan Lee, 2022, Critical Care.

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Karl Erik Müller, Jose M. Mandei, C. A. Shaw, 2021, Infection.